Entellus Medical has agreed to pay about 3.4 million in shares of its common stock, valued at approximately $56 million, and $25 million in cash for Redwood City, Calif.-based Spirox, maker of the Latera Absorbable Nasal Implant. The acquisition, which includes four years of additional contingent payments depending on revenue growth, is expected to expand Entellus' portfolio of products designed for sinusitis treatment.
Spirox to be acquired by Entellus Medical in $81M deal
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.